Metamason Inc., a Los Angeles, CA-based healthcare-focused 3D scanning and 3D printing company, raised $3m in seed funding.
The round was led by 3P Equity Partners, a manufacturing-focused private equity firm located in San Jose, CA; and Tsing Capital, a Chinese cleantech venture capital firm, with participation from individual angel investors throughout the country.
The company intends to use the funds to complete FDA regulatory clearance and run initial clinical trials for its patent-pending flagship product Respere™.
Led by founder and CEO Leslie Oliver Karpas, and COO/CFO and co-founder Cliff Sarkin, Metamason is advancing Respere™, a custom fit, 3D-printed CPAP mask that combines proprietary process (Scan·Fit·Print™) 3D body scanning, patented algorithmic design and on-demand 3D printing to treat Obstructive Sleep Apnea, a chronic respiratory disorder affecting 1 in 4 men and 1 in 9 women in the US alone.
The company plans to execute a crowdfunding campaign later in 2016 and begin marketing activities in early 2017.
FinSMEs
03/06/2016